January 13, 2017

A Crohn’s Story: Kevin’s Life With IBD

Crohn’s disease is an inflammatory bowel disease that affects approximately three in every 1,000 people. One of those people is Kevin Heimbach. Want to know what it’s like to grow up with inflammatory ... Read more

October 5, 2015October 5, 2015

AstraZeneca’s AZD9056 Shows Promise in Phase IIa Study on Moderate to Severe Crohn’s Disease

News

According to a recently published study, AstraZeneca’s AZD9056 – an orally-available purinergic receptor P2X7 antagonist, may be effective in symptom improvement in patients with moderate to severe Crohn’s disease. The study is ... Read more